Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $9.87 billion. The enterprise value is $13.23 billion.
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026, after market close.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 60.77 million shares outstanding. The number of shares has decreased by -10.58% in one year.
| Current Share Class | 60.77M |
| Shares Outstanding | 60.77M |
| Shares Change (YoY) | -10.58% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 101.10% |
| Float | 58.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.48 |
| PS Ratio | 2.40 |
| Forward PS | 2.20 |
| PB Ratio | 2.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.36 |
| P/OCF Ratio | 7.07 |
| PEG Ratio | 0.52 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.22, with an EV/FCF ratio of 9.90.
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | 8.22 |
| EV / EBIT | 14.34 |
| EV / FCF | 9.90 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 1.37.
| Current Ratio | 1.65 |
| Quick Ratio | 1.24 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 4.06 |
| Interest Coverage | 3.10 |
Financial Efficiency
Return on equity (ROE) is -9.06% and return on invested capital (ROIC) is 5.83%.
| Return on Equity (ROE) | -9.06% |
| Return on Assets (ROA) | 4.88% |
| Return on Invested Capital (ROIC) | 5.83% |
| Return on Capital Employed (ROCE) | 10.16% |
| Revenue Per Employee | $1.48M |
| Profits Per Employee | -$131,601 |
| Employee Count | 2,800 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | -335.32M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.59% in the last 52 weeks. The beta is 0.27, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +33.59% |
| 50-Day Moving Average | 162.62 |
| 200-Day Moving Average | 129.01 |
| Relative Strength Index (RSI) | 44.25 |
| Average Volume (20 Days) | 1,050,096 |
Short Selling Information
The latest short interest is 5.04 million, so 8.30% of the outstanding shares have been sold short.
| Short Interest | 5.04M |
| Short Previous Month | 4.97M |
| Short % of Shares Out | 8.30% |
| Short % of Float | 8.56% |
| Short Ratio (days to cover) | 3.12 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.16 billion and -$368.48 million in losses. Loss per share was -$6.06.
| Revenue | 4.16B |
| Gross Profit | 3.82B |
| Operating Income | 922.50M |
| Pretax Income | -703.80M |
| Net Income | -368.48M |
| EBITDA | 1.61B |
| EBIT | 922.50M |
| Loss Per Share | -$6.06 |
Full Income StatementBalance Sheet
The company has $2.05 billion in cash and $5.43 billion in debt, with a net cash position of -$3.38 billion or -$55.67 per share.
| Cash & Cash Equivalents | 2.05B |
| Total Debt | 5.43B |
| Net Cash | -3.38B |
| Net Cash Per Share | -$55.67 |
| Equity (Book Value) | 3.96B |
| Book Value Per Share | 65.18 |
| Working Capital | 1.48B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.39 billion and capital expenditures -$55.31 million, giving a free cash flow of $1.34 billion.
| Operating Cash Flow | 1.39B |
| Capital Expenditures | -55.31M |
| Free Cash Flow | 1.34B |
| FCF Per Share | $21.99 |
Full Cash Flow StatementMargins
Gross margin is 91.98%, with operating and profit margins of 22.19% and -8.86%.
| Gross Margin | 91.98% |
| Operating Margin | 22.19% |
| Pretax Margin | -16.93% |
| Profit Margin | -8.86% |
| EBITDA Margin | 38.67% |
| EBIT Margin | 22.19% |
| FCF Margin | 32.14% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.58% |
| Shareholder Yield | 10.58% |
| Earnings Yield | -3.74% |
| FCF Yield | 13.58% |
Dividend DetailsAnalyst Forecast
The average price target for JAZZ is $207.19, which is 27.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $207.19 |
| Price Target Difference | 27.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 6.61% |
| EPS Growth Forecast (5Y) | 23.59% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 5 |
